Medical Therapy. Efficacy or Lack of Efficacy

Propranolol treatment for chylothorax after congenital cardiac surgery

Rozelle Corda, Sophia Chrisomalis-Dring, Sarah Crook, Carrie J. Shawber, June K. Wu, Paul J. ChaiNew York Presbyterian/Morgan Stanley Children’s Hospital, Columbia University Irving Medical Center and Vagelos College of Physicians & SurgeonsUnited States Journal of Thoracic and Cardiovascular SurgeryJ Thorac Cardiovasc Surg 2022; 163: 1630-1641DOI: 10.1016/j.jtcvs.2021.09.007 AbstractObjective: Postoperative chylothorax causes significant morbidities in pediatric patients with cardiac […]

Propranolol treatment for chylothorax after congenital cardiac surgery Read More »

Neonatal lymphatic flow disorders: central lymphatic flow disorder and isolated chylothorax, diagnosis and treatment using novel lymphatic imaging and interventions technique

Deborah Rabinowitz, Kevin Dysart, Maxim ItkinNemours Children’s Hospital. Sidney Kimmel Medical College at Thomas Jefferson University. Perelman School of Medicine at the University of Pennsylvania. United States Current Opinion in PediatricsCurr Opin Pediatr 2022; 34: 191-196DOI: 10.1097/MOP.0000000000001109 AbstractPurpose of review: Neonatal lymphatic disorders (NLDs) are conditions that are relatively rare and difficult to treat. The recent development

Neonatal lymphatic flow disorders: central lymphatic flow disorder and isolated chylothorax, diagnosis and treatment using novel lymphatic imaging and interventions technique Read More »

Treatment and outcomes of chylothorax in children: 20-year experience of a single institute

Kanokpan Ruangnapa, Wanaporn Anuntaseree, Kantara Saelim, Pharsai Prasertsan, Maneerat Puwanant, Supaporn DissanevatePrince of Songkla UniversityThailand Journal of Thoracic DiseaseJ Thorac Dis 2022; 14: 3719-3726DOI: 10.21037/jtd-22-474 AbstractBackground: Chylothorax is an uncommon cause of pleural effusion in children. This study aimed to determine the characteristics, treatment strategies, and outcomes of chylothorax in children from a single institute.Methods: The 65 episodes

Treatment and outcomes of chylothorax in children: 20-year experience of a single institute Read More »

Assessing growth of infants with chylothorax receiving fortified skimmed human breast milk

Brittani Clark, Melissa Froh, Catherine Karls, Mary Beth Feuling, Praveen Goday, Michael Uhing, Stephanie S. Handler, T. Hang Nghiem-Rao, Elizabeth PolzinChildren’s Wisconsin and Medical College of Wisconsin.United States Nutrition in Clinical PracticeNutr Clin Pract 2023; 38: 199-203DOI: 10.1002/ncp.10887 AbstractLearning outcome: To learn how skimmed human milk (SHM) can be used in infants with chylothorax to support adequate

Assessing growth of infants with chylothorax receiving fortified skimmed human breast milk Read More »

Propranolol Therapy for Congenital Chylothorax

Roxane Handel-Orefice, Bevin Midura, June K. Wu, Elvira Parravicini, Russell S. Miller, Carrie J. ShawberColumbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Morgan Stanley Children’s HospitalUnited States PediatricsPediatrics 2023; 151: DOI: 10.1542/peds.2022-058555 AbstractCongenital chylothorax is a rare and often severe anomaly without well-established medical therapies. Previously, propranolol use in patients with lymphatic malformations

Propranolol Therapy for Congenital Chylothorax Read More »

Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review

Alan C. Jenkinson, Jonathan McGuinness, Terence PrendivilleChildren’s Heart Centre and Children’s Health Ireland at Crumlin. Ireland Pediatric CardiologyPediatr Cardiol 2023; 44: 297-305DOI: 10.1007/s00246-022-03024-6 AbstractChylothorax is a life-threatening complication post-corrective congenital heart surgery. Octreotide is used for treatment of refractory chylothoraces, with no standardized treatment protocol and a paucity of literature describing its efficacy. Our aim was

Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review Read More »

Diagnosis and treatment of diffuse pulmonary lymphangioma in children: A case report

Xiaopu Sun, Chengyu Lu, Zhanhang Huang, Jiaxing Xu, Huiyi Zhu, Sen Yang, Deihui ChenThe First Affiliated Hospital of Guangzhou Medical University.China Experimental and Therapeutic MedicineExp Ther Med 2023; 25: DOI: 10.3892/etm.2023.11874 AbstractThe present study aimed to investigate the clinical characteristics of diffuse pulmonary lymphangioma (DPL) in children to improve the diagnosis and treatment of this disease.

Diagnosis and treatment of diffuse pulmonary lymphangioma in children: A case report Read More »

Effects of a Long-Term Wearable Activity Tracker-Based Exercise Intervention on Cardiac Morphology and Function of Patients with Cystic Fibrosis

Maria Anifanti, Stavros Giannakoulakos, Elpis Hatziagorou, Asterios Kampouras, John Tsanakas, Asterios Deligiannis, Evangelia KouidiAristotle University of Thessaloniki and Hippokration Hospital. Greece SensorsSensors 2022; 22: DOI: 10.3390/s22134884 AbstractSeveral studies have shown that patients with cystic fibrosis (CF), even at a young age, have pulmonary and cardiac abnormalities. The main complications are cardiac right ventricular (RV) systolic and/or

Effects of a Long-Term Wearable Activity Tracker-Based Exercise Intervention on Cardiac Morphology and Function of Patients with Cystic Fibrosis Read More »

Long-Term Study on Therapeutic Strategy for Treatment of Eisenmenger Syndrome Patients: A Case Series Study

Yi-Ching Liu, Yu-Wen Chen, I-Chen Chen, Yen-Hsien Wu, Shih-Hsing Lo, Jui-Sheng Hsu, Jong-Hau Hsu, Bin-Nan Wu, Yi-Fang Cheng, Zen-Kong DaiKaohsiung Medical University Hospital. Taiwan ChildrenChildren 2022; 9: DOI: 10.3390/children9081217 AbstractEisenmenger syndrome (ES) refers to congenital heart diseases (CHD) with reversal flow associated with increased pulmonary pressure and irreversible pulmonary vascular remodeling. Previous reports showed limited therapeutic

Long-Term Study on Therapeutic Strategy for Treatment of Eisenmenger Syndrome Patients: A Case Series Study Read More »

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension

Yan Wu, Fu-Hua Peng, Xin Gao, Xin-Xin Yan, FengWen Zhang, Jiang-Shan Tan, Song Hu, Lu HuaFuwai Hospital and Chinese Academy of Medical Sciences and Peking Union Medical College.China Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2022; DOI: 10.3389/fcvm.2022.918735 AbstractBackground: Chronic calcium channel blockers (CCBs) are indicated in children with idiopathic/heritable pulmonary arterial hypertension (IPAH/HPAH) and positive response to

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension Read More »

Scroll to Top